- Home
- APLE vs VKTX Comparison
APLE vs VKTX Comparison
Compare APLE & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLE
- VKTX
- Stock Information
- Founded
- APLE 2007
- VKTX 2012
- Country
- APLE United States
- VKTX United States
- Employees
- APLE N/A
- VKTX N/A
- Industry
- APLE Real Estate Investment Trusts
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- APLE Real Estate
- VKTX Health Care
- Exchange
- APLE Nasdaq
- VKTX Nasdaq
- Market Cap
- APLE 2.9B
- VKTX 3.0B
- IPO Year
- APLE 2015
- VKTX 2015
- Fundamental
- Price
- APLE $11.67
- VKTX $31.60
- Analyst Decision
- APLE Buy
- VKTX Strong Buy
- Analyst Count
- APLE 7
- VKTX 12
- Target Price
- APLE $14.71
- VKTX $86.42
- AVG Volume (30 Days)
- APLE 2.7M
- VKTX 5.3M
- Earning Date
- APLE 11-03-2025
- VKTX 10-22-2025
- Dividend Yield
- APLE 8.24%
- VKTX N/A
- EPS Growth
- APLE N/A
- VKTX N/A
- EPS
- APLE 0.76
- VKTX N/A
- Revenue
- APLE $1,423,951,000.00
- VKTX N/A
- Revenue This Year
- APLE $1.09
- VKTX N/A
- Revenue Next Year
- APLE $2.21
- VKTX N/A
- P/E Ratio
- APLE $15.42
- VKTX N/A
- Revenue Growth
- APLE 2.42
- VKTX N/A
- 52 Week Low
- APLE $10.44
- VKTX $18.92
- 52 Week High
- APLE $16.50
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- APLE 31.00
- VKTX 62.28
- Support Level
- APLE $11.91
- VKTX $25.04
- Resistance Level
- APLE $12.22
- VKTX $26.96
- Average True Range (ATR)
- APLE 0.21
- VKTX 1.67
- MACD
- APLE -0.07
- VKTX 1.00
- Stochastic Oscillator
- APLE 2.11
- VKTX 88.05
About APLE Apple Hospitality REIT Inc.
Apple Hospitality REIT Inc is a real estate investment trust that invests in income-producing real estate, majorly in the lodging sector, in the United States. It chiefly invests in upscale service hotels. All of the company's hotels operate under the Marriott or Hilton brands. Apple Hospitality has wholly-owned taxable REIT subsidiaries, which lease all of the company's hotels from wholly-owned qualified REIT subsidiaries. These hotels are managed under separate agreements with various hotel management companies that are unaffiliated with Apple Hospitality. The company derives its income from hotel revenue, its sole segment.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.